Research on Circulation Management Strategy Based on Oxygen Metabolism Balance After CHD Surgery
Launched by CHILDREN'S HOSPITAL OF FUDAN UNIVERSITY · Dec 18, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study firstly offered a specialized treatment strategy for children, particularly those who have undergone cardiopulmonary bypass surgery, that uses tailored parallel control and is independent of absolute oxygen supply and consumption characteristics.In addition, this study seeks to investigate the correlation between oxygen supply and consumption following pediatric cardiopulmonary bypass surgery and to assess the clinical utility of a goal-directed strategy concerning cardiac function recovery (ICON, echocardiography, myocardial markers) and outcomes (incidence of low cardiac output...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1.Body weight \> 2.5kg;
- • 2.Preoperative oxygen saturation \>80%;
- • 3.Biventricular radical surgery with cardiopulmonary bypass.
- Exclusion Criteria:
- • 1. Complicated with functional single ventricle and atrial isomerism;
- • 2.Complicated with liver, kidney, lung, brain and other vital organ diseases;
- • 3.History of rescue before operation;
- • 4.Palliative surgery;
- • 5.Residual deformities that significantly affected hemodynamics after operation;
- • 6.Guardians did not provide the bundle of informed consent.
About Children's Hospital Of Fudan University
The Children's Hospital of Fudan University is a leading pediatric healthcare institution in China, renowned for its commitment to advancing child health through innovative research and clinical excellence. As a prominent clinical trial sponsor, the hospital focuses on conducting high-quality, ethically-driven studies that aim to improve pediatric care and treatment outcomes. With a multidisciplinary team of experienced healthcare professionals and researchers, the hospital leverages its robust infrastructure and expertise to facilitate groundbreaking clinical trials, ensuring the safety and well-being of child participants while contributing valuable insights to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Minhang, Shanghai, China
Patients applied
Trial Officials
Ping Ya Mi
Study Director
Children's Hospital of Fudan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported